Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

NCT07454031 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal (Metastatic) Cancer

Interventions

DRUG: intraperitoneal PX in combination with nab-paclitaxel

Sponsor

Peking University

Collaborators

[object Object]